TruthArchive.ai - Related Video Feed

The speaker discusses the spread of bird flu and the potential for mass culling of poultry. They mention the development of bird flu vaccines and the possibility of human-to-human transmission. The conversation also touches on the lack of human trials for vaccines and the FDA's approval process based on preclinical data. The focus is on the need for vaccination, particularly for farm workers.

Coronavirus, as a pathogen model, was identified in 1965 and seen as modifiable for various purposes. In 1966, it was used in a transatlantic biological experiment. By 1967, human trials began, inoculating people with modified versions. The common cold was turned into a chimera in the 1970s. By 1990, coronavirus was an industrial problem for dog and pig breeders, leading to Pfizer's first spike protein vaccine patent. However, from 1990 to 2018, research indicated coronavirus mutated too quickly for vaccines to be effective. In 2002, the University of North Carolina Chapel Hill patented an "infectious replication defective" clone of coronavirus, funded by NIAID's Anthony Fauci, preceding SARS 1.0. SARS is engineered, not naturally occurring like the common cold.

Vince agrees that flu is a major pathogen with high virulence and transmissibility. Other pathogens may have one but not the other. The panel focuses on flu proposals, which is a common sentiment among those outside the field as well.

We need to be proactive in searching for emerging diseases before they become a global threat. Peter Daszak, who collaborated with the Wuhan Institute of Virology, discovered 50 previously unknown Coronaviruses in bats. These Coronaviruses have the potential to jump from wildlife to humans. Our organization works with labs worldwide, subcontracting the work and ensuring we have a country program officer in each location to manage our projects.

In 1965, coronavirus was identified as a pathogen that could be modified for various purposes. The first human manipulation experiment took place in 1966, followed by transatlantic data sharing in 1967. In the 1970s, coronavirus was modified in animals like pigs and dogs. By 1990, it was discovered that coronavirus caused gastrointestinal issues in dogs and pigs, leading to Pfizer filing the first spike protein vaccine patent. The spike protein was not a new problem, as it was known since 1990. Vaccines for coronavirus have been ineffective due to its ability to mutate quickly, as stated in numerous independent scientific publications. In 2002, the University of North Carolina Chapel Hill patented an infectious replication defective clone of coronavirus, funded by Anthony Fauci. This suggests that SARS was engineered and not a naturally occurring phenomenon.

We isolated coronaviruses from animals in the past to understand their threat to other species by culturing them on different cell types. This process, known as gain of function, involves enriching mutants that can infect new species. The speaker emphasizes that mass vaccination in humans is a significant gain of function experiment, leading to virus evolution. This real-world experiment involves constant virus changes due to human-to-human transmission under vaccine pressure.

In 1965, coronavirus was identified as a pathogen that could be modified for various purposes. The first transatlantic coronavirus experiment took place in 1966, followed by human trials in 1967. In the 1970s, coronavirus was manipulated in animals, and by 1990, it was recognized as a problem for dogs and pigs. Pfizer filed the first spike protein vaccine patent in 1990. It was known since then that coronavirus mutates too quickly for vaccines to be effective. In 2002, the University of North Carolina Chapel Hill patented an infectious replication defective clone of coronavirus, funded by Anthony Fauci. SARS 1.0 was engineered and not a naturally occurring phenomenon.

The world's perception of influenza needs to change in order to address the problem effectively. There is a possibility of a novel avian virus outbreak in China, which could have devastating consequences. If another pandemic were to occur, millions of people could die within a short period of time. Disruptive and iterative approaches are necessary to tackle this issue. The government has a role to play in pushing the industry to prioritize public health over profit. The perception of influenza is not as serious as other diseases, which makes it difficult to bring about change. Resources need to be allocated more efficiently during crises, and synthetic-based vaccines could revolutionize the field. The goal is to align different capabilities, funding streams, and incentives towards a common goal. More resources and financial incentives could attract new talent to the field.

Coronavirus was isolated in 1965 and quickly identified as a pathogen for experimentation. In 1966, the first COV model was used in human manipulation experiments. By 1990, Pfizer patented a spike protein vaccine for coronavirus. Research showed vaccines were ineffective due to the virus mutating rapidly. In 2002, the University of North Carolina patented an infectious replication defective clone of coronavirus, funded by Anthony Fauci. This work preceded SARS 1.0 by a year, suggesting engineered origins.

Coronavirus was isolated in 1965 as one of the first infectious replicatable viral models, associated with the common cold. In 1966, the very first COV coronavirus model was used as a transatlantic biological experiment in human manipulation. In 1967, the first human trials on inoculating people with modified coronavirus were conducted. Between 1975 and 1977, we started modifying coronavirus by putting it into different animals, pigs and dogs. By 1990, Pfizer's first spike protein vaccine patent for coronavirus was filed. From 1990 to 02/2018, every publication on coronavirus vaccines concluded that coronavirus escapes the vaccine impulse because it mutates too quickly. In 02/2002, UNC Chapel Hill patented ‘an infectious replication defective clone of coronavirus’ funded by NIAID's Anthony Fauci from 1999 to 02/2002. That work allegedly preceded SARS-1; SARS is the research developed by humans weaponizing a life system model to attack human beings, patented in 02/2002.

The speakers discuss the need for a new and improved method of vaccine production. They acknowledge the challenges of transitioning from the current egg-growing process to a more efficient method. The process of proving the effectiveness of a new vaccine and going through clinical trials can take up to a decade. They suggest the need for a disruptive entity that is not bound by bureaucratic processes to address the problem of influenza. They also mention the possibility of using RNA sequences from novel avian viruses in China to create vaccines that can be self-administered through patches.

The NIH is developing a universal vaccine that addresses the entire phylum of viruses. This vaccine mimics natural immunity and is effective against any kind of mutation. It doesn't drive the virus to mutate. The researchers believe it could be effective not only against coronaviruses but also against influenza. The vaccine is described as much safer and much more effective. The exchange then notes that Mark, did you take your question again? and Mark is prompted to ask his question.

The transmission of avian bird flu from animals to humans is rare. We should allow farms with chickens and cows to develop natural immunity, as they are constantly being reinfected by migratory mallard ducks and waterfowl. The practice of culling is not effective.

Birds don't get flu. Birds do not get influenza. Birds can get sick, but they haven't got flu, and it's not contagious. So, the PCR test is a measure of nothing. It's fraud. So and they could make the birds sick in any number of ways just by treating them badly. If they overcrowd them, that will make them sick. If they stress them, that will make them sick. And if they then come in and test them, they can claim bird flu in the flock, then they can kill all the birds, and then they can say, oh, look. Bird flu is going around. It doesn't even exist because like I told you, birds don't get colds. Birds don't sneeze. Have you ever seen a bird coughing? And I wouldn't think monkeys get pox either. Really. They're hairy.

We can't just shut down our current vaccine system and immediately switch everyone to a new, untested vaccine. To move beyond traditional egg-based vaccine production, which has served us well, we need a demonstrably superior alternative. This requires extensive clinical trials, potentially taking a decade even under ideal circumstances. Perhaps we need a disruptive entity, free from bureaucratic constraints. It’s difficult to alter perceptions of influenza unless we address the problem disruptively and iteratively from within. Imagine if a novel avian virus emerged in China, we could obtain its RNA sequence and transmit it to regional or even local centers, possibly even directly to homes, to print vaccines on patches for self-administration.

The situation has been horrific, leading to a shift in research and development budgets. Current vaccines primarily focus on improving individual health but only slightly reduce transmission. There is a need for a new approach to vaccine development that effectively blocks transmission.

There is a lack of knowledge and organization regarding infectious diseases in this country, leading to panic and unreasonable plans. The fear of a highly contagious and deadly virus like avian flu caused unnecessary concern. However, the speaker explains that the flu cannot cause the same level of mortality as it did in the past due to various reasons. The contagiousness of respiratory diseases is limited, with each patient infecting an average of two people. The exaggerated response to these diseases, resembling a nuclear threat, should be managed by medical professionals rather than government agencies.

For over 20 years, flu shot rates in seniors sharply increased, but flu deaths among the elderly continue to climb. NIH researchers conducted a study adjusting for factors masking the shots' benefits, but found flu shots haven't reduced deaths among the elderly. We sought out Dr. Reichert, who confirmed the study's surprising results, which were also found in Australia, France, Canada, and the UK. Despite billions spent, promoting flu shots in seniors hasn't had the desired result. The CDC is considering new strategies but still recommends seniors get vaccinated to lessen flu severity and prevent other issues. The CDC will likely shift towards protecting the elderly by vaccinating more children and those around them.

Bird flu could potentially lead to a pandemic that is much more severe than COVID-19. It's not a matter of if, but when this will happen. When bird flu infects humans, it has a high mortality rate, estimated between 25% and 50%. The situation becomes critical once the virus can attach to human receptors and spread from person to person. Given these factors, it is likely that we will face a bird flu pandemic in the future.

This video discusses the coronavirus and the ongoing research programs to develop vaccines against similar viruses that have previously crossed over from animals to humans. The question is raised whether these viruses can be modified or adapted to combat the current virus. This research is being conducted globally, including in China.

Scientists can learn how to teach the flu virus how to infect human tissue, and some are already doing this. The scientific community isn't trying to cause a pandemic, but they are arrogant about their ability to contain a respiratory pathogen. COVID evolved from scientific experiments in a laboratory that was trying to do good things, like make a vaccine vector, but it escaped, and over 20,000,000 people died. Nature will continue to try to change, but the species barrier for amino acids is pretty high. Some scientists believe gain of function research is needed to protect humanity against emerging pathogens, but they don't consider the fact that they may be emerging them like with COVID.

In 1965, coronavirus was identified as a pathogen that could be modified for various purposes. In 1966, the first transatlantic biological experiment using a coronavirus model was conducted. In 1967, human trials were conducted on modified coronavirus. In 1990, Pfizer filed the first patent for a spike protein vaccine for coronavirus. It was found that coronavirus mutates too quickly for vaccines to be effective. In 2002, the University of North Carolina Chapel Hill patented an infectious replication defective clone of coronavirus. The CDC filed a patent on SARS coronavirus isolated from humans in 2003. The RT PCR test for coronavirus was identified as a bioterrorism threat in 2002. Gain of function research on coronavirus was exempted from a moratorium in 2014. In 2016, a journal article stated that SARS coronavirus was poised for human emergence. In 2019, Moderna modified patent applications to include the term "accidental or intentional release of a respiratory pathogen." The goal was to create a universal vaccine template. The intent was to use coronavirus to achieve this. The speaker concludes by calling for an end to gain of function research and corporate patronage of science without assuming product liability.

Researchers have been working on making bird flu more contagious for humans through gain of function research. The virus mainly infects chickens and sometimes cattle. Chinese vaccination efforts in the 90s may have worsened the situation. The current strain, H5N1 avian influenza, has caused around 800-900 human cases with a high mortality rate in Southeast Asia. Recent US cases were easily treated. The virus is not a significant threat unless it starts spreading human to human. The recent strain may have originated from experiments on mallard ducks in Georgia, leading to its spread across states. The media has not questioned this spread caused by migratory waterfowl.

We're discussing the urgent need for a better flu vaccine that can protect against all types of influenza viruses. To tackle this challenge, we require passionate and talented individuals from diverse backgrounds to collaborate. By combining unconventional thinking, we can find faster solutions. Unlike measles, which remains consistent over time, influenza constantly changes due to mutations. This means that a new vaccine is needed each year to match the circulating virus. Occasionally, there are major changes in the virus caused by mutations or when it jumps species, resulting in a unique situation. Other viral infections like polio, smallpox, and measles do not exhibit this level of variability.

If we ignore the problem of felons in the US, we'll face more issues like H5N2 bird flu. The alleged H5N, avian influenza, is available for sale on the BEI Resources website since 2016. The concern lies in gain of function research in labs, where the recipe to make bird flu highly infectious for humans is already known.